Your browser doesn't support javascript.
loading
Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon.
Li, Hong; Liang, Shan; Liu, Lili; Zhou, Daqiong; Liu, Yali; Zhang, Yang; Chen, Xinyue; Zhang, Jing; Cao, Zhenhuan.
Afiliação
  • Li H; The Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Liang S; The Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Liu L; The Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Zhou D; The Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Liu Y; The Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Zhang Y; Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Chen X; The First Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Zhang J; The Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Cao Z; The Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Front Immunol ; 13: 1091786, 2022.
Article em En | MEDLINE | ID: mdl-36618361

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Fígado Gorduroso Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Fígado Gorduroso Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article